|
|
Volumn 86, Issue 6, 2012, Pages 645-652
|
|
Hormonal contraception and HIV acquisition risk: Implications for individual users and public policies
|
|
Author keywords
DMPA; HIV acquisition; Hormonal contraception; Policy implications
|
|
Indexed keywords
LEVONORGESTREL;
MEDROXYPROGESTERONE ACETATE;
NORETHISTERONE ENANTATE;
ORAL CONTRACEPTIVE AGENT;
ARTICLE;
CONDOM;
COST BENEFIT ANALYSIS;
DRUG USE;
DRUG WITHDRAWAL;
FAMILY PLANNING;
FEMALE;
FEMALE STERILIZATION;
HEALTH CARE COST;
HEALTH CARE POLICY;
HORMONAL CONTRACEPTION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION RISK;
INTRAUTERINE CONTRACEPTIVE DEVICE;
KENYA;
MAJOR CLINICAL STUDY;
MALE;
MALE STERILIZATION;
MATERNAL MORTALITY;
PREVALENCE;
SOUTH AFRICA;
ZIMBABWE;
ADOLESCENT;
ADULT;
AFRICA SOUTH OF THE SAHARA;
CONTRACEPTION BEHAVIOR;
CONTRACEPTIVE AGENTS, FEMALE;
DRUG IMPLANTS;
FAMILY PLANNING SERVICES;
FEMALE;
HEALTH POLICY;
HEALTH PROMOTION;
HIV INFECTIONS;
HUMANS;
MALE;
MEDROXYPROGESTERONE ACETATE;
MIDDLE AGED;
PREGNANCY;
PREGNANCY, UNWANTED;
RISK;
SEX WORKERS;
SEXUAL BEHAVIOR;
SEXUAL PARTNERS;
YOUNG ADULT;
|
|
EID: 84869094323
PISSN: 00107824
EISSN: 18790518
Source Type: Journal
DOI: 10.1016/j.contraception.2012.03.008 Document Type: Article |
|
Times cited : (29)
|
|
References (15)
|
